Valeant strengthens derm franchise as it buys podiatry-focused Pedinol
This article was originally published in Scrip
Executive Summary
Specialty pharma Valeant Pharmaceuticals has bought podiatry-focused drug maker Pedinol Pharmacal, based in Farmingdale, New York, which specialises in making prescription and OTC treatments for foot disorders.